课题基金 / 基金详情

University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program

University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program
德克萨斯大学西南分校 - 促进住院医师研究 (UT-StARR) 计划
批准号:
10655275
负责人:
DWIGHT A. TOWLER
金额:
$33.48万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2025-06-30

项目摘要

项目成果

DWIGHT A. TOWLER的其他基金

相似基金

相关文献

中文摘要
翻译
工程摘要 尽管在理解和治疗心脏和肺部疾病方面进行了数十年的研究, 心血管疾病和肺部疾病仍然是老年人住院、残疾和死亡的主要原因。 美国值得注意的是,越来越多的儿童期慢性疾病患者,如先天性心脏病, 缺陷,囊性纤维化,支气管肺发育不良,血友病,存活到成年,使它 必须进行涵盖生命周期的研究。在这一关键研究需求的背景下, 医学博士的短缺正在急剧增加科学家,这样的比例,医学博士,仍然主要是 在过去的30年里,尽管医生总数不断攀升, 在实践中医学博士的管道-科学家的发展也处于危险之中:很少有医学生对 研究生涯,更少的毕业生申请国家卫生研究院的资金。重要的是,相对于整体医生, 劳动力、妇女和少数民族在医学博士中的比例不成比例地偏低。科学家 这些挑战需要实施创新的招聘和培训战略,以满足医学博士的需求。 科学家管道,并确保妇女和少数民族的代表性。为了帮助填补这些关键空白,我们 将建立得克萨斯州西南大学(UTSW)-刺激获得研究, 住院医师(UT-StARR)培训计划,招募和培训内科和儿科的多元化群体 他们将成为下一代医学博士科学家们进行基于实验室的,转化的, 临床和人口健康研究,以检测,治疗和预测影响心脏,肺, 和血液的混合物。我们的机构将提供一个理想的环境, 多学科骨干资助的研究;强大的教学培训计划;和多样化的患者人群。我们 假设UTSW -MD的三个多样性轴学员,导师和患者社区-提供 独特的机会,以解决医学未满足的需求。研究培训、个性化医疗和人口 健康以下目标组织了我们的方法:目标1。提供基础广泛的综合辅导, 为一组不同的内科和儿科住院研究员提供研究培训, 设计和实施以实验室为基础的、转化的、临床的和人群的疾病研究 影响心脏,肺和血液,包括检测,预防,治疗和结果,以改善 个人和人口在整个人类寿命期间的健康;目标2。提供必要的研究 培训和指导平台需要建立一个坚实的基础,使居民能够成功过渡 独立医学博士在心脏、肺和血液领域进行生物医学研究的科学家;目标3。到 通过实施,加强来自代表性不足群体的医学博士在研究中的参与和坚持 和维护机构指导的住院医师培训计划,涉及不同的居民,导师, 通过评估和监测UT-StARR和其他机构培训计划的进展,
英文摘要
Project Abstract Despite decades of research in the understanding and treatment of diseases of the heart and lung, cardiovascular and pulmonary diseases remain the leading causes of hospitalization, disability, and death in the U.S. Notably, growing numbers of patients with childhood-onset chronic illnesses, such as congenital heart defects, cystic fibrosis, bronchopulmonary dysplasia, and hemophilia, are surviving into adulthood, making it imperative to conduct research encompassing the lifespan. Against this background of critical research needs, there is a strikingly growing shortage of M.D.-scientists, such that the proportion of M.D.s that remain primarily in research careers has decreased by 3-fold in the last 3 decades, despite the climbing number of total physicians in practice. The pipeline of M.D.-scientist development is also at risk: fewer medical students express interest in a research career, and fewer graduates apply for NIH funding. Importantly, relative to the overall physician workforce, women and minorities are disproportionately underrepresented in the proportion of M.D.-scientists. These challenges require the implementation of innovative recruitment and training strategies to feed the M.D.- scientist pipeline and ensure that women and minorities are well-represented. To help fill these critical gaps, we will establish the University of Texas Southwestern (UTSW) - Stimulating Access to Research in Residency (UT-StARR) training program to recruit and train a diverse group of Internal Medicine and Pediatrics residents that will become the next generation of M.D.-scientists conducting laboratory-based, translational, clinical, and population health research to detect, treat, and prognosticate diseases affecting the heart, lungs, and blood of diverse populations throughout the lifespan. Our institution will provide an ideal environment with a multidisciplinary cadre of funded research; robust didactic training program; and diverse patient population. We hypothesize that the 3 axes of diversity at UTSW - M.D. trainees, mentors, and patient community - afford the unique opportunity to address unmet needs in M.D. research training, personalized medicine, and population health. The following Aims organize our approach: Aim 1. To provide broad-based comprehensive mentored research training for a group of diverse Internal Medicine and Pediatric resident-investigators in the conception, design, and implementation of laboratory-based, translational, clinical, and population research in diseases affecting the heart, lungs and blood, encompassing detection, prevention, treatment, and outcomes to improve the health of individuals and populations throughout the human lifespan; Aim 2. To provide the essential research training and mentoring platform needed to build a strong foundation allowing successful transition of residents to independent M.D.-scientists conducting biomedical research in the heart, lung, and blood fields; Aim 3. To enhance the participation and persistence of M.D.s from underrepresented groups in research by implementation and maintenance of institutional mentored residency training programs involving diverse residents, mentors, and patients through evaluation and monitoring the progress of UT-StARR and other institutional training programs.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Novel Biomarkers of Kidney Disease in Advanced Heart Failure: Beyond GFR and Proteinuria.
晚期心力衰竭中肾脏疾病的新型生物标志物:超越GFR和蛋白尿。
DOI: 10.1007/s11897-022-00557-y
发表时间: 2022-08
期刊: Current heart failure reports
影响因子: --
作者: []
通讯作者:
Association of Ratio of eGFR by Cystatin C and Creatinine with Mortality in Heart Failure.
胱抑素 C 和肌酐的 eGFR 比率与心力衰竭死亡率的关联。
DOI: 10.34067/kid.0000000000000384
发表时间: 2024
期刊: Kidney360
影响因子: --
作者: [Roehm,Bethany, McAdams,Meredith, Gordon,Jonathan, Grodin,JustinL, Hedayati,SSusan]
通讯作者: Hedayati,SSusan
Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry.
心力衰竭住院患者的转诊和出院后心脏康复利用模式:来自 GWTG-HF 登记处的分析。
DOI: 10.1161/circheartfailure.122.010144
发表时间: 2023
期刊: Circulation. Heart failure
影响因子: --
作者: [Keshvani,Neil, Subramanian,Vinayak, Wrobel,ChristopherA, Solomon,Nicole, Alhanti,Brooke, Greene,StephenJ, DeVore,AdamD, Yancy,ClydeW, Allen,LarryA, Fonarow,GreggC, Pandey,Ambarish]
通讯作者: Pandey,Ambarish
Specific Gravity Improves Identification of Clinically Significant Quantitative Proteinuria from the Dipstick Urinalysis.
比重可改善试纸尿液分析中临床显着的定量蛋白尿的识别。
DOI: 10.34067/kid.0000000000000452
发表时间: 2024
期刊: Kidney360
影响因子: --
作者: [McAdams,MeredithC, Gregg,LParker, Xu,Pin, Zhang,Song, Li,Michael, Carroll,Ella, Kannan,Vaishnavi, Willett,DuWayneL, Hedayati,SSusan]
通讯作者: Hedayati,SSusan
Cdc42bpg signaling in arteriosclerosis and vascular fibrosis
  • 批准号:
    10448070
  • 项目类别:
  • 资助金额:
    $16.4万
  • 财政年份:
    2022
  • 负责人:
    DWIGHT A. TOWLER
  • 依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
  • 批准号:
    8856647
  • 项目类别:
  • 资助金额:
    $39.77万
  • 财政年份:
    2012
  • 负责人:
    DWIGHT A. TOWLER
  • 依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
海外基金